The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ESPERION THERAPEUTICS INC NE COMMON 29664W105 12,114 167,487 SH   DFND 1 0 0 167,487
ESPERION THERAPEUTICS INC NE COMMON 29664W105 7 100 SH   DFND   0 0 100
MACROGENICS INC. COMMON 556099109 24,592 977,426 SH   DFND 1 0 0 977,426
MEDICINES CO COMMON 584688105 9,819 298,095 SH   DFND 1 0 0 298,095
MEDICINES CO COMMON 584688105 101,297 3,075,202 SH   DFND 2 0 0 3,075,202
MEDICINES CO COMMON 584688105 3 100 SH   DFND   0 0 100
MIRATI THERAPEUTICS INC COMMON 60468T105 96,274 3,135,966 SH   DFND 1 0 0 3,135,966
PTC THERAPEUTICS INC. COMMON 69366J200 2,363 87,330 SH   DFND 1 0 0 87,330